Search Results for citation:"90 FR 16137"

The National Institutes of Health announced a change to the National Advisory Council on Minority Health and Health Disparities meeting, initially scheduled for hybrid participation on May 6, 2025. The meeting will now be conducted virtually, with part of it closed to the public. This update was originally published in the Federal Register on March 31, 2025. The Supervisory Program Analyst, David W. Freeman, provided this amendment.

The National Cancer Institute has announced a closed meeting to take place on May 9, 2025. This meeting, part of the Federal Advisory Committee Act, will review and evaluate contract proposals and will be held virtually. Confidentiality will be maintained to protect sensitive trade secrets and personal privacy. The session will run from 9:00 a.m. to 6:00 p.m., and any inquiries can be directed to Shamala K. Srinivas, Ph.D.

The National Institute of Allergy and Infectious Diseases is considering granting an exclusive patent license to Cambridge Enterprise Limited, part of the University of Cambridge, to develop and market certain inventions. These inventions involve conductive polymer coated electrodes used for single-cell electroporation in clinical settings. This license would help consolidate patent rights and speed up the commercial development of the invention, which is in line with promoting innovation according to U.S. law. Public comments or applications for this license must be submitted by May 2, 2025, and will be considered by the institute.